Accuracy of Magnetic Resonance Imaging (MRI) in Predicting Aggressiveness of Early Breast Cancer According to Molecular Subtypes Identified by ER PR and HER-2 Status
Phase 4
18 Years
N/A
18 Years
N/A
Open (Enrolling)
Female
Invasive Breast Cancer
Female
Invasive Breast Cancer
Trial Information
Accuracy of Magnetic Resonance Imaging (MRI) in Predicting Aggressiveness of Early Breast Cancer According to Molecular Subtypes Identified by ER PR and HER-2 Status
Dedicated Contrast-enhanced Magnetic Resonance Imaging (DCE-MRI)
Inclusion Criteria:
- Patients with invasive ductal carcinoma
- Patients undergoing DCE-MRI scan which are assessed according to BI-RADS lexicon
- Breast cancer patients with pathological diagnosed invasive ductal carcinoma with
hormonal receptor (ER, PR and HER-2) response
- Patients who have signed on informed consent form Patients will undergo MRI imaging
and the physicians will practice according to practice guidelines.
Exclusion Criteria:
- Patients under 18 years old or during pregnancy
- Patients with MRI's contraindications e.g. patients with cardiac pacemaker or are
allergic to MRI contrast agent Patients with unstable clinical abnormality and might
get unexpected clinical treatment
Type of Study:
Interventional
Study Design:
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
study the benefits of DCE-MRI using Gadovist in prognostic determination of early invasive breast cancer
Outcome Description:
The benefits of breast tumor diagnosis from DCE-MRI in early invasive breast cancer with poor prognostic features
Outcome Time Frame:
1 year
Safety Issue:
No
Principal Investigator
Pornpim Korpraphong, M.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
Mahidol University
Authority:
Thailand: Ethical Committee
Study ID:
15262
NCT ID:
NCT01597999
Start Date:
February 2011
Completion Date:
December 2013
Related Keywords:
- Invasive Breast Cancer
- Breast Neoplasms
Name | Location |
|---|
